Results 161 to 170 of about 975,042 (316)

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

New England Journal of Medicine, 2017
J. Taylor-Cousar, A. Munck, E. McKone, C. van der Ent, A. Moeller, C. Simard, Linda T. Wang, E. Ingenito, C. Mckee, Yimeng Lu, J. Lekstrom-Himes, S. Elborn   +11 more
semanticscholar   +1 more source

Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry.

Journal of Cystic Fibrosis, 2020
E. Hatziagorou, A. Orenti, P. Dřevínek, N. Kashirskaya, M. Mei-Zahav, K. De Boeck, A. Pfleger, Muriel Thomas Sciensano, E. Lammertyn, M. Macek, H. Olesen, Anne Farge, L. Naehrlich, R. Újhelyi, G. Fletcher, R. Padoan, Zane Timpare, K. Malakauskas, S. Fuštik, V. Gulmans, O. Turcu, L. Pereira, S. Moşescu, M. Rodić, H. Kayserová, U. Krivec, Carlos Vázquez-Cordero, I. de Monestrol, A. Lindblad, A. Jung, H. Makukh, S. Carr, R. Cosgriff, A. Zolin   +33 more
semanticscholar   +1 more source

Diagnostic dilemma of cystic biliary atresia: A series of two cases and brief review of the diagnostic modalities

JPGN Reports, EarlyView.
Abstract Cystic biliary atresia (CBA) is a rare variant of biliary atresia that closely resembles choledochal cyst (CC), complicating diagnosis and potentially delaying critical surgical intervention. We report two cases of CBA that were difficult to diagnose.
Hamza Hassan Khan, Leslie Hirsig Spence, Nagraj Kasi   +2 more
wiley   +1 more source

Autonomous sweat extraction and analysis applied to cystic fibrosis and glucose monitoring using a fully integrated wearable platform

Proceedings of the National Academy of Sciences of the United States of America, 2017
S. Emaminejad, W. Gao, E. Wu, Z. Davies, Hnin Yin Yin Nyein, Samyuktha Challa, Sean P. Ryan, H. Fahad, Kevin Chen, Ziba Shahpar, Salmonn Talebi, C. Milla, A. Javey, Ronald W. Davis   +13 more
semanticscholar   +1 more source

Infantile exocrine pancreatic insufficiency due to a homozygous SPINK1 pathogenic variant in two siblings: A case report

JPGN Reports, EarlyView.
Abstract Infantile exocrine pancreatic insufficiency is a rare condition, most often encountered in the context of cystic fibrosis or Shwachman–Diamond syndrome. The SPINK1 gene encodes a trypsin inhibitor protein that prevents the premature activation of digestive enzymes in pancreatic tissue.
France Chalon, Angélique Lhomme, Marie Léonard, Laura Zambelli, Serpil Alkan, Corinne Fasquelle, Aimé Lumaka, Guillaume Debray, Vincent Bours, Julie Frère, Emeline Bequet   +10 more
wiley   +1 more source

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis

ERJ Open Research, 2018
Akhil Sawant, Giulia Spoletini, Paul Whitaker, Christine Etherington, Ian Clifton, Daniel Peckham   +5 more
doaj   +1 more source

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]

Pediatr Pulmonol
Kümmerli S, Elviro CF, Regamey N, Mornand A, Faouzi M, Rochat I, Blanchon S.   +6 more
europepmc   +1 more source

Nasal endoscopic and CT scan alterations of the paranasal sinuses as predictors of severity in patients with cystic fibrosis

, 2013
Marcos Rabelo de Freitas, Deborah Vasconcelos, Ângela Elizabeth de Holanda Araújo Freitas, José Holanda Maia Filho, Claudia de Castro e Silva   +4 more
openalex   +1 more source

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease.

Journal of Cystic Fibrosis, 2020
S. Kapnadak, E. DiMango, D. Hadjiliadis, S. Hempstead, E. Tallarico, J. Pilewski, A. Faro, J. Albright, C. Benden, S. Blair, E. Dellon, Daniel U Gochenour, P. Michelson, B. Moshiree, I. Neuringer, Carl Riedy, T. Schindler, L. Singer, Dave Young, Lauren Vignola, Joan Zukosky, R. Simon   +21 more
semanticscholar   +1 more source

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender, Rosalind Hughes, Brian Kirby   +2 more
wiley   +1 more source